Trial Profile
Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 16 Dec 2015 Status changed from recruiting to completed as reported in ClinicalTrials.gov
- 20 Feb 2015 Planned End Date changed from 1 Dec 2014 to 1 May 2015 as reported in ClinicalTrials.gov
- 20 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 May 2015 as reported in ClinicalTrials.gov